
Please try another search
First validation of C4XD's patient sub-groups through a Garvan-led retrospective clinical trial analysis Promising initial result paves way for novel approaches in Parkinson's disease...
By Samuel Indyk Investing.com – C4X Discovery Holdings PLC (LON:C4XD), a UK-based pharmaceutical company, announced today that its subsidiary C4X Discovery Limited has signed an exclusive...
LONDON (Reuters) - Britain's C4X Discovery said on Tuesday it was confident of striking partnership deals for its programmes in therapy areas such as sickle cell, cancer and inflammation,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review